SUBSCRIBE
SUBSCRIBE

Teva Pharmaceutical Industries Limited Announces Launch of Generic Prometrium® Capsules in the United States

March 2, 2012 | 
1 min read
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the commercial launch of Progesterone Capsules, 100 & 200 mg, the AB-rated generic equivalent of Abbott Laboratories’ Prometrium® Capsules.
Asia Europe
MORE ON THIS TOPIC
IN PARTNERSHIP WITH IQVIA
AI Is Taking Over Drug Safety Monitoring–But There’s One Thing It Can’t Replace
July 17, 2025
 · 
1 min read
 · 
Lori Ellis
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
A pill with the Amercan and Chinese flag wrapped around it
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
June 20, 2025
 · 
2 min read
 · 
Tristan Manalac
3d illustration of a black dragon flying on an extraterrestrial world with mountains beneath.
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac